Mirtazapine
Product Images NDC 71610-369

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 15 mg (71610 0369 15)

Bottle Label 15 mg (71610 0369 15)
Mirtazapine USP label for 15 mg tablets, package containing 15 tablets. The label includes storage instructions, NDC 71610-0369-15, and manufacturer information for Apotex Inc., with repackaging by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of mirtazapine, showing its heterocyclic ring system with nitrogen atoms and a methyl group attached to the piperazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.